FDA expects that any COVID-19 vaccine it licenses should prevent the disease or decrease its severity in at least 50% of people vaccinated, according to guidance that the agency released today.
The recommendation, which FDA said reflects the advice the agency has provided vaccine developers in recent months, was part of an overall document called “Development and Licensure of Vaccines to Prevent COVID-19″ that provides a host of guidelines for vaccine developers.
The goal of the guidance is to ensure that the rush to produce a COVID-19 vaccine results in vaccines that are both safe and effective.
Get the full story on our sister site Drug Discovery & Development.